GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » COGS-to-Revenue

Tci Gene (ROCO:6879) COGS-to-Revenue : 0.47 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tci Gene COGS-to-Revenue?

Tci Gene's Cost of Goods Sold for the six months ended in Dec. 2023 was NT$87.1 Mil. Its Revenue for the six months ended in Dec. 2023 was NT$184.0 Mil.

Tci Gene's COGS to Revenue for the six months ended in Dec. 2023 was 0.47.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Tci Gene's Gross Margin % for the six months ended in Dec. 2023 was 52.64%.


Tci Gene COGS-to-Revenue Historical Data

The historical data trend for Tci Gene's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene COGS-to-Revenue Chart

Tci Gene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
0.30 0.38 0.45 0.43 0.48

Tci Gene Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only 0.47 0.42 0.43 0.48 0.47

Tci Gene COGS-to-Revenue Calculation

Tci Gene's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=159.238 / 333.855
=0.48

Tci Gene's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=87.142 / 183.992
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tci Gene  (ROCO:6879) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Tci Gene's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 87.142 / 183.992
=52.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Tci Gene COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Tci Gene's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Tci Gene (ROCO:6879) Business Description

Traded in Other Exchanges
N/A
Address
No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines